Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Berenberg lowers target price on Travis Perkins

(Sharecast News) - Analysts at Berenberg lowered their target price on builders' merchant and home improvement retailer Travis Perkins from 880.p to 800.0p on Thursday, stating times were "still tough" for the company. Berenberg stated it struggles to get excited about Travis Perkins given the continued pressures it faces on both volumes and margins in 2024, and also said it thinks the business' elevated financial leverage "raises a few concerns".

However, it did note the group's proactivity in reducing costs and optimising cash flow through a series of differing initiatives that will leave it better positioned to benefit from the recovery when it comes.

"Considering these factors and the current valuation we keep our 'hold' rating but lower our price target to 800.0p as we cut 2024-26 EBITA forecasts by 10% following the FY 2023 results," said Berenberg.

The German bank added that Travis Perkins trades on 16x 2024 earnings per share, falling to 12x in 2025.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

AstraZeneca makes progress with two breast cancer treatments
(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.
Insurer Beazley keeps guidance after solid Q1 premiums growth
(Sharecast News) - Insurance group Beazley said that first-quarter results were in line with guidance with insurance written premiums (IWP) growing at high single digits.
Blackstone ups bid for Hipgnosis with $1.57bn offer
(Sharecast News) - Music rights owner Hipgnosis said it it agreed terms on a £1.2bn takeover by private equity investor Blackstone, in the latest tit-for-tat battle with rival Concord.
Aukett Swanke flags delays to some contracts
(Sharecast News) - Smart buildings, architectural and design services specialist Aukett Swanke said in an update on Friday that, as outlined in its recent financial statements, it maintained a robust pipeline of interest, although a number of projects had been pushed back.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.